Annual report pursuant to Section 13 and 15(d)

Aytu Divestiture - Narrative (Details)

Aytu Divestiture - Narrative (Details) - USD ($) shares in Millions		10 Months Ended	12 Months Ended		15 Months Ended
	Nov. 01, 2019	Oct. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jan. 31, 2021	Jun. 30, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of pediatric portfolio			$ 0	$ 7,964,924
Remaining contingent consideration						$ 7,300,000
Change in fair value on guarantee			1,755,000	0
Deerfield Obligation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contingent consideration paid		$ 3,200,000
Deerfield Obligation \| Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Periodic payment					$ 100,000
Deerfield Obligation \| AYTU
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Balloon payment to be paid						$ 15,000,000.0
Remaining contingent consideration	$ 9,300,000
Deerfield Obligation \| AYTU \| Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Periodic payment					100,000
Balloon payment to be paid					$ 15,000,000.0
AYTU
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Monthly commercial operation payments	$ 12,000
AYTU \| Maximum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Duration of monthly commercial operation payments	18 months
AYTU \| Convertible Preferred Stock
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Investment, shares (in shares)	9.8
Pediatric Portfolio
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of pediatric portfolio				8,000,000.0
Pediatric Portfolio \| Deerfield Obligation \| AYTU
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Periodic payment	$ 300,000
Quarterly deferred payments, percentage of net sales of pediatric products	15.00%
Future aggregate deferred payments	$ 12,500,000
Discontinued Operations, Disposed of by Sale \| Pediatric Portfolio
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of assets	4,500,000			4,500,000
Assumption of debt on sale of assets	15,100,000
Gain on sale of pediatric portfolio			0	7,964,924
Change in fair value on guarantee			1,755,000	0
Sales returns disposed of	800,000
Sales return reserve			$ 1,000,000.0
Net assets transferred	18,800,000
Transaction expenses	600,000
Discontinued Operations, Disposed of by Sale \| Pediatric Portfolio \| Maximum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sales returns disposed of	2,800,000
Discontinued Operations, Disposed of by Sale \| Pediatric Portfolio \| Minimum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sales returns disposed of	2,000,000.0
Discontinued Operations, Disposed of by Sale \| Pediatric Portfolio \| AYTU
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Liabilities assumed by buyer	$ 11,000,000.0
Convertible preferred stock received				$ 7,600,000